FDA Calendar for POZEN Inc. (POZN)

| Register (free)
POZEN Inc. (POZEN), is a pharmaceutical company focused on developing products, which can provide improved efficacy, safety or patient convenience in the treatment of acute and chronic pain, and pain related conditions. The Company has developed Treximet (formerly known as Trexima) in collaboration with GlaxoSmithKline (GSK). Treximet is the brand name for the product combining sumatriptan 85 milligram, formulated with RT Technology and naproxen sodium 500 milligram in a single tablet designed for the acute treatment of migraine. On April 15, 2008, the United States Food and Drug Administration (FDA) approved Treximet for the acute treatment of migraine attacks with or without aura in adults. Treximet incorporates the Company’s MT 400 technology, which refers to its combinations of a triptan (5-HT1B/1D agonist) and a non-steroidal, anti-inflammatory drug (NSAID).


Drug Pipeline

Drug NameType Of DrugFDA StatusDrug Phase
Vimovo Other ApprovedNDA


Events

No future events listed at this time, please check back later.
1 past event(s) found. Click here to view them.

Add New Event

In order to write a comment you must first login.

Login or Register (for free!)

Add Event

POZN

$4.74
0.19 +4.18%
2/3/2012 4:00:00 PM

Sponsors

Other Links